{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:09:50Z","timestamp":1784408990544,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"DOI":"10.7759\/cureus.84252","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:37:13Z","timestamp":1747453033000},"source":"Crossref","is-referenced-by-count":1,"title":["Leukocytoclastic Vasculitis With Eosinophilia in a Patient Receiving Dupilumab Therapy"],"prefix":"10.7759","author":[{"given":"Alex  M","family":"Wandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Dupixent FDA package insert. (2024). Accessed. April 8, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761055s064lbl.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.08.048","article-title":"A case of leukocytoclastic vasculitis in a patient on dupilumab","volume":"42","author":"Bach MS","year":"2023","unstructured":"Bach MS, Keeling BH, Yim E. A case of leukocytoclastic vasculitis in a patient on dupilumab. JAAD Case Rep. 2023, 42:49-51. 10.1016\/j.jdcr.2023.08.048","journal-title":"JAAD Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02415-6","article-title":"Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report","volume":"23","author":"Suzaki I","year":"2023","unstructured":"Suzaki I, Tanaka A, Yanai R, Maruyama Y, Kamimura S, Hirano K, Kobayashi H. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report. BMC Pulm Med. 2023, 23:130. 10.1186\/s12890-023-02415-6","journal-title":"BMC Pulm Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0823","article-title":"Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes","volume":"32","author":"Olaguibel JM","year":"2022","unstructured":"Olaguibel JM, Sastre J, Rodr\u00edguez JM, Del Pozo V. Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes. J Investig Allergol Clin Immunol. 2022, 32:165-80. 10.18176\/jiaci.0823","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02688-x","article-title":"Diagnosis and management of leukocytoclastic vasculitis","volume":"16","author":"Fraticelli P","year":"2021","unstructured":"Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021, 16:831-41. 10.1007\/s11739-021-02688-x","journal-title":"Intern Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.053","article-title":"Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort","volume":"81","author":"Faiz S","year":"2019","unstructured":"Faiz S, Giovannelli J, Podevin C, et al.. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort. J Am Acad Dermatol. 2019, 81:143-51. 10.1016\/j.jaad.2019.02.053","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92330-z","article-title":"Analysis and mining of dupilumab adverse events based on FAERS database","volume":"15","author":"Gao H","year":"2025","unstructured":"Gao H, Cao L, Liu C. Analysis and mining of dupilumab adverse events based on FAERS database. Sci Rep. 2025, 15:8597. 10.1038\/s41598-025-92330-z","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358503-leukocytoclastic-vasculitis-with-eosinophilia-in-a-patient-receiving-dupilumab-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:37:17Z","timestamp":1747453037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358503-leukocytoclastic-vasculitis-with-eosinophilia-in-a-patient-receiving-dupilumab-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.84252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}